Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination

SIMPLE SUMMARY: The aim of this study is to analyze the feasibility and tolerance of primary concurrent radio–chemotherapy in breast cancer patients. The primary systemic treatment of breast cancer aims to limit the scope of subsequent surgery by reducing the size of the tumor allowing for less exte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciérvide, Raquel, Montero, Ángel, García-Rico, Eduardo, García-Aranda, Mariola, Herrero, Mercedes, Skaarup, Jessica, Benassi, Leticia, Barrera, Maria José, Vega, Estela, Rojas, Beatriz, Bratos, Raquel, Luna, Ana, Parras, Manuela, López, María, Delgado, Ana, Quevedo, Paloma, Castilla, Silvia, Feyjoo, Margarita, Higueras, Ana, Prieto, Mario, Suarez-Gauthier, Ana, Garcia-Cañamaque, Lina, Escolán, Nieves, Álvarez, Beatriz, Chen, Xin, Alonso, Rosa, López, Mercedes, Hernando, Ovidio, Valero, Jeannette, Sánchez, Emilio, Ciruelos, Eva, Rubio, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496977/
https://www.ncbi.nlm.nih.gov/pubmed/36139688
http://dx.doi.org/10.3390/cancers14184531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496977/
https://www.ncbi.nlm.nih.gov/pubmed/36139688
http://dx.doi.org/10.3390/cancers14184531

Ejemplares similares